正中开胸上腔静脉人工血管置换的程序化处理在胸部肿瘤外科治疗中的应用

BACKGROUND The involvement of superior vena cava is a common condition in locally advanced thoracic tumors. Patients may benefit from the high risk operation. This study proposed a programmed procedure to optimize surgical techniques, which can facilitate the safety of operation via median thoracotomy. METHODS A total of 35 patients with thoracic disease involved superior vena cava underwent prosthetic vascular reconstruction via median thoracotomy. All patients were confirmed locally advanced without distant metastasis including 16 pulmonary neoplasm and 19 mediastinal disease. The operations proceed from left to right with one direction manner. The initial part of the left innominate vein was dissected, then cut off, so as to lift tumor, the pericardium was opened, and the left innominate vein and the right artrium were bridged with prosthetic vascular. The proximal end of the superior vena cava which not invaded was dissected and the tumor was pulled to the caudal side, the right mediastinal pleura was opened and the right inner mammary vascular was ligated and the right innominate vein was fully revealed. Stretch the tumor to left top, cut azygos vein on above the hilum, then block the right innominate vein and superior vena cava, removed involved part of blood vessels, the right innominate vein and superior vena cava was connected with prosthetic vascular. With these procedures the superior vena cava was reconstructed completely. RESULTS The operation was completed successfully in all cases. Postoperative complications included 6 cases with arrhythmia, 5 cases with hypoxemia, 1 case with myasthenia crisis, 1 case with cardiac hernia, and 2 cases with fungal infection. 2 patients died of myocardial infarction and lung infection respectively with a mortality rate of 5.12%. The remaining 33 cases were discharged successfully. The average postoperative hospital stay was 15 days. Of the 10 patients with superior vena cava syndrome preoperatively, 8 patients had symptoms relief except 2 cases with intraoperative intravascular thrombosis. CONCLUSIONS We recommended the programmed procedure of prosthetic reconstruction of the superior vena cava, standardize the details of treatment, and minimize the risk during operation. The safe surgical procedures of this group of cases confirm this practice.

[1]  Kenji Suzuki,et al.  Patency of grafts after total resection and reconstruction of the superior vena cava for thoracic malignancy , 2016, Surgery Today.

[2]  Yong-Hee Kim,et al.  Prosthetic graft interposition of the brachiocephalic veins or superior vena cava combined with resection of malignant tumours: graft patency and risk factors for graft occlusion. , 2016, Journal of thoracic disease.

[3]  Kenji Suzuki,et al.  Long-term survival after superior vena cava resection and reconstruction for bulky local recurrence from lung cancer. , 2015, Interactive cardiovascular and thoracic surgery.

[4]  Y. Sekine,et al.  Prosthetic reconstruction of the superior vena cava for malignant disease: surgical techniques and outcomes. , 2010, The Annals of thoracic surgery.

[5]  J. Picquet,et al.  Surgical reconstruction of the superior vena cava system: indications and results. , 2009, Surgery.

[6]  L. Politi,et al.  Prosthetic replacement and tangential resection of the superior vena cava in chest tumors. , 2007, The Journal of cardiovascular surgery.

[7]  D. Radice,et al.  Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases. , 2007, The Annals of thoracic surgery.

[8]  R. S. Dhaliwal,et al.  Management of superior vena cava syndrome by internal jugular to femoral vein bypass. , 2006, The Annals of thoracic surgery.

[9]  H. Matsuda,et al.  Long-term graft patency after replacement of the brachiocephalic veins combined with resection of mediastinal tumors. , 2005, The Journal of thoracic and cardiovascular surgery.

[10]  R. Tsuchiya,et al.  Results of superior vena cava resection for lung cancer. Analysis of prognostic factors. , 2004, Lung cancer.

[11]  R. Ginsberg,et al.  15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer. , 2003, Lung cancer.

[12]  C. Lequaglie,et al.  The difficult approach to neoplastic superior vena cava syndrome: surgical option. , 2003, The Journal of cardiovascular surgery.

[13]  J. Panneton,et al.  Superior vena cava syndrome: relief with a modified saphenojugular bypass graft. , 2001, Journal of vascular surgery.